NSPR Relative Valuation
NSPR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, NSPR is overvalued; if below, it's undervalued.
Historical Valuation
InspireMD Inc (NSPR) is now in the Fair zone, suggesting that its current forward PS ratio of 6.45 is considered Fairly compared with the five-year average of -2.13. The fair price of InspireMD Inc (NSPR) is between 1.40 to 3.35 according to relative valuation methord.
Relative Value
Fair Zone
1.40-3.35
Current Price：1.81
Fair
-2.30
PE
1Y
3Y
5Y
-0.34
EV/EBITDA
InspireMD Inc. (NSPR) has a current EV/EBITDA of -0.34. The 5-year average EV/EBITDA is -0.39. The thresholds are as follows: Strongly Undervalued below -1.97, Undervalued between -1.97 and -1.18, Fairly Valued between 0.40 and -1.18, Overvalued between 0.40 and 1.19, and Strongly Overvalued above 1.19. The current Forward EV/EBITDA of -0.34 falls within the Historic Trend Line -Fairly Valued range.
-0.28
EV/EBIT
InspireMD Inc. (NSPR) has a current EV/EBIT of -0.28. The 5-year average EV/EBIT is -0.47. The thresholds are as follows: Strongly Undervalued below -2.80, Undervalued between -2.80 and -1.63, Fairly Valued between 0.70 and -1.63, Overvalued between 0.70 and 1.86, and Strongly Overvalued above 1.86. The current Forward EV/EBIT of -0.28 falls within the Historic Trend Line -Fairly Valued range.
6.45
PS
InspireMD Inc. (NSPR) has a current PS of 6.45. The 5-year average PS is 6.39. The thresholds are as follows: Strongly Undervalued below -2.30, Undervalued between -2.30 and 2.04, Fairly Valued between 10.74 and 2.04, Overvalued between 10.74 and 15.08, and Strongly Overvalued above 15.08. The current Forward PS of 6.45 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
InspireMD Inc. (NSPR) has a current P/OCF of 0.00. The 5-year average P/OCF is 0.20. The thresholds are as follows: Strongly Undervalued below -10.81, Undervalued between -10.81 and -5.30, Fairly Valued between 5.70 and -5.30, Overvalued between 5.70 and 11.21, and Strongly Overvalued above 11.21. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
InspireMD Inc. (NSPR) has a current P/FCF of 0.00. The 5-year average P/FCF is 0.94. The thresholds are as follows: Strongly Undervalued below -12.98, Undervalued between -12.98 and -6.02, Fairly Valued between 7.90 and -6.02, Overvalued between 7.90 and 14.86, and Strongly Overvalued above 14.86. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
InspireMD Inc (NSPR) has a current Price-to-Book (P/B) ratio of 1.22. Compared to its 3-year average P/B ratio of 1.66 , the current P/B ratio is approximately -26.74% higher. Relative to its 5-year average P/B ratio of 1.40, the current P/B ratio is about -13.01% higher. InspireMD Inc (NSPR) has a Forward Free Cash Flow (FCF) yield of approximately -43.25%. Compared to its 3-year average FCF yield of -46.86%, the current FCF yield is approximately -7.71% lower. Relative to its 5-year average FCF yield of -54.96% , the current FCF yield is about -21.32% lower.
1.22
P/B
Median3y
1.66
Median5y
1.40
-43.25
FCF Yield
Median3y
-46.86
Median5y
-54.96
Competitors Valuation Multiple
The average P/S ratio for NSPR's competitors is 14.63, providing a benchmark for relative valuation. InspireMD Inc Corp (NSPR) exhibits a P/S ratio of 6.45, which is -55.87% above the industry average. Given its robust revenue growth of 39.39%, this premium appears sustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of NSPR decreased by 29.84% over the past 1 year. The primary factor behind the change was an increase in Revenue Growth from 1.81M to 2.52M.
The secondary factor is the Margin Expansion, contributed 15.55%to the performance.
Overall, the performance of NSPR in the past 1 year is driven by Revenue Growth. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is InspireMD Inc (NSPR) currently overvalued or undervalued?
InspireMD Inc (NSPR) is now in the Fair zone, suggesting that its current forward PS ratio of 6.45 is considered Fairly compared with the five-year average of -2.13. The fair price of InspireMD Inc (NSPR) is between 1.40 to 3.35 according to relative valuation methord.
What is InspireMD Inc (NSPR) fair value?
NSPR's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of InspireMD Inc (NSPR) is between 1.40 to 3.35 according to relative valuation methord.
How does NSPR's valuation metrics compare to the industry average?
The average P/S ratio for NSPR's competitors is 14.63, providing a benchmark for relative valuation. InspireMD Inc Corp (NSPR) exhibits a P/S ratio of 6.45, which is -55.87% above the industry average. Given its robust revenue growth of 39.39%, this premium appears sustainable.
What is the current P/B ratio for InspireMD Inc (NSPR) as of Jan 07 2026?
As of Jan 07 2026, InspireMD Inc (NSPR) has a P/B ratio of 1.22. This indicates that the market values NSPR at 1.22 times its book value.
What is the current FCF Yield for InspireMD Inc (NSPR) as of Jan 07 2026?
As of Jan 07 2026, InspireMD Inc (NSPR) has a FCF Yield of -43.25%. This means that for every dollar of InspireMD Inc’s market capitalization, the company generates -43.25 cents in free cash flow.
What is the current Forward P/E ratio for InspireMD Inc (NSPR) as of Jan 07 2026?
As of Jan 07 2026, InspireMD Inc (NSPR) has a Forward P/E ratio of -2.30. This means the market is willing to pay $-2.30 for every dollar of InspireMD Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for InspireMD Inc (NSPR) as of Jan 07 2026?
As of Jan 07 2026, InspireMD Inc (NSPR) has a Forward P/S ratio of 6.45. This means the market is valuing NSPR at $6.45 for every dollar of expected revenue over the next 12 months.